Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Kagan

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Translational Medicine|August 17, 2017
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomicsHui Wang, Christopher E Barbieri, Jintang He, et al.
European Urology Focus|July 30, 2017
Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient CohortJennifer Cullen, Denise Young, Yongmei Chen, et al.
Disease Markers|July 20, 2004
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancerWilliam E Grizzle, Bao-Ling L Adam, William L Bigbee, et al.
Cancers|May 21, 2020
Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer ProgressionYuqian Gao, Yi-Ting Wang, Yongmei Chen, et al.
Clinical Chemistry|November 21, 2007
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerDale McLerran, William E Grizzle, Ziding Feng, et al.
Journal of Proteome Research|March 13, 2020
National Cancer Institute Think-Tank Meeting Report on Proteomic Cartography and Biomarkers at the Single-Cell Level: Interrogation of Premalignant LesionsJacob Kagan, Robert L Moritz, Richard Mazurchuk, et al.
Journal of Translational Medicine|April 19, 2015
Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methodsJintang He, Athena A Schepmoes, Tujin Shi, et al.
Clinical Chemistry|November 6, 2007
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample biasDale McLerran, William E Grizzle, Ziding Feng, et al.
Molecular Oncology|October 1, 2014
Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancerJintang He, Xuefei Sun, Tujin Shi, et al.
Clinical Chemistry|December 23, 2004
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibilityO John Semmes, Ziding Feng, Bao-Ling Adam, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|August 17, 2017
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomicsHui Wang, Christopher E Barbieri, Jintang He, et al.
European Urology Focus|July 30, 2017
Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient CohortJennifer Cullen, Denise Young, Yongmei Chen, et al.
Disease Markers|July 20, 2004
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancerWilliam E Grizzle, Bao-Ling L Adam, William L Bigbee, et al.
Cancers|May 21, 2020
Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer ProgressionYuqian Gao, Yi-Ting Wang, Yongmei Chen, et al.
Clinical Chemistry|November 21, 2007
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerDale McLerran, William E Grizzle, Ziding Feng, et al.
Journal of Proteome Research|March 13, 2020
National Cancer Institute Think-Tank Meeting Report on Proteomic Cartography and Biomarkers at the Single-Cell Level: Interrogation of Premalignant LesionsJacob Kagan, Robert L Moritz, Richard Mazurchuk, et al.
Journal of Translational Medicine|April 19, 2015
Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methodsJintang He, Athena A Schepmoes, Tujin Shi, et al.
Clinical Chemistry|November 6, 2007
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample biasDale McLerran, William E Grizzle, Ziding Feng, et al.
Molecular Oncology|October 1, 2014
Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancerJintang He, Xuefei Sun, Tujin Shi, et al.
Clinical Chemistry|December 23, 2004
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibilityO John Semmes, Ziding Feng, Bao-Ling Adam, et al.
Pageof 5